Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Preferences, or utilities, for health outcomes are central in prostate cancer decision-making. Utilities can be elicited directly from patients using standard techniques, or indirectly, using questionnaires that incorporate preference weights from community members. OBJECTIVES: To evaluate directly elicited and indirectly elicited (questionnaire-derived, community-weighted) utilities for prostate cancer outcomes and the effects of sexual, urinary, and bowel dysfunction on them. MATERIALS AND METHODS: Utilities for the current health of 141 prostate cancer patients, recruited from ambulatory clinics, were elicited directly with the Patient Oriented Prostate Utility Scale, rating scale (PORPUS-U(RS)) and standard gamble (PORPUS-U(SG)) subscales. Patients completed the Health Utilities Index (HUI) and Quality of Well Being Scale (QWB), utility instruments incorporating community preferences, and the UCLA Prostate Cancer Index. RESULTS: Patients' treatments included radical prostatectomy (18%), radiation (60%), and hormonal (42%). Mean utility scores for current health were 0.65 (QWB), 0.79 (PORPUS-U(RS)), 0.80 (HUI), 0.86 (PORPUS-U(SG)). Utility decrements for dysfunction were small (0.08-0.14 [sexual], 0.06 to 0.13 [urinary], and 0.01 to 0.13 [bowel]), and even smaller when adjusted for concomitant changes in other quality of life (QOL) domains. CONCLUSIONS: Patients' directly elicited utilities for their own health were higher than community-derived utilities obtained from HUI and QWB administration to the same patients. HUI scores of these patients were similar to those of age-matched Canadian men. Sexual, urinary, and bowel problems were common but had less impact on overall QOL than reported in previous utility studies. These results weaken the argument that prostate cancer screening and treatment should be limited because of severe and debilitative side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary data exists to support these clinical observations; studies have found the couples where the male partner reported ED also reported less intimate contact, and lower scores on togetherness and tenderness within the relationship [43, 44]”
From Prostate cancer: Psychosocial implications and management (2008) · cites this paper as [43]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Theory of games and economic behavior
(2019) · 100 Years of Math Milestones · doi:10.1090/mbk/121/32 · Cited by 16,632
The Expected Utility Model: Its Variants, Purposes, Evidence and Limitations
Schoemaker, P. J. H. (2007) · Journal of Economic Literature · Cited by 1,829
Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System
Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., Depauw, S., Denton, M., & Boyle, M. (2002) · Medical Care · doi:10.1097/00005650-200202000-00006 · Cited by 1,332
Utility approach to measuring health-related quality of life
Torrance, G. W. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90019-1 · Cited by 1,072
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., Albertsen, P. C., Harlan, L. C., & Potosky, A. L. (2000) · JAMA · doi:10.1001/jama.283.3.354 · Cited by 956
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998) · Medical Care · doi:10.1097/00005650-199807000-00007 · Cited by 825
Multi-Attribute Health Status Classification Systems: Health Utilities Index
Feeny, D., Furlong, W., Boyle, M., & Torrance, G. W. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507060-00004 · Cited by 820
Research works printed but not linked: 11
- Krahn, 1999, Can Med Assoc J, 160, 49
- Cantor, 1995, J Fam Pract, 41, 33
- Krahn, 1994, JAMA, 272, 773, 10.1001/jama.272.10.773 · doi:10.1001/jama.272.10.773 · Paper page
- Mold, 1992, J Fam Pract, 34, 561
- Litwin, 2001, J Urol, 166, 587, 10.1016/s0022-5347(05)65989-7 · doi:10.1016/s0022-5347(05)65989-7
- Kattan, 1997, J Gen Intern Med, 12, 299, 10.1007/s11606-006-5066-9 · doi:10.1007/s11606-006-5066-9
- Bennett, 1997, Eur Urol, 32, 86
- Shoemaker, 1982, J Economic Lit, 20, 529
- Kaplan, 1988, Health Serv Res, 23, 203
- Nease, 1995, JAMA, 273, 1185, 10.1001/jama.273.15.1185 · doi:10.1001/jama.273.15.1185 · Paper page
- Krahn, 1996, Med Decis Making, 16, 470
Cited by
Symptom Burden: Multiple Symptoms and Their Impact as Patient-Reported Outcomes
Cleeland, C. S. (2007) · JNCI Monographs · doi:10.1093/jncimonographs/lgm005 · Cited by 455
Longworth, L., Yang, Y., Young, T., Mulhern, B., Hernández Alava, M., Mukuria, C., Rowen, D., Tosh, J., Tsuchiya, A., Evans, P., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18090 · Cited by 417
Catalona, W. J. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.11.001 · Cited by 197
Korfage, I. J., Essink‐Bot, M., Borsboom, G. J. J. M., Madalinska, J. B., Kirkels, W. J., Habbema, J. D. F., Schröder, F. H., & de Koning, H. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21043 · Cited by 195
Proton therapy of cancer: Potential clinical advantages and cost-effectiveness
Lundkvist, J., Ekman, M., Ericsson, S. R., Jönsson, B., & Glimelius, B. (2005) · Acta Oncologica · doi:10.1080/02841860500341157 · Cited by 172
Metadata
- Authors
- Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Krahn, Murray
- Ritvo, Paul
- Irvine, Jane
- Bremner, Karen E.
- Naglie, Gary
- ORCID
- Venue
- Medical Care
- Published
- 2003-01
- Volume
- 41
- Issue
- 1
- Pages
- 153-164
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2325586243
- Cited by
- 119
- References
- 51
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 11 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 22.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Keywords
- prostate cancer, health-related quality of life, patient preferences, community preferences, sexual dysfunction, urinary dysfunction, bowel dysfunction, standard gamble, Health Utilities Index, Quality of Well-Being Scale, UCLA Prostate Cancer Index, prostate cancer screening, treatment side effects
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Combined Modality Therapy, Data Interpretation, Statistical, Decision Making, Health Policy, Humans, Intestinal Diseases, Male, Middle Aged, Prostatectomy, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Sexual Dysfunction, Physiological, Urinary Incontinence, Treatment Outcome, Patient Satisfaction, Sickness Impact Profile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy. https://app.cochat.ai/papers/10.1097/00005650-200301000-00017
- The paper
- Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003). Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy. Medical Care. https://doi.org/10.1097/00005650-200301000-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.